Form D · Biotechnology
StemoniX, Inc.
Maple Grove, MN · CIK 0001663434
Offering snapshot reported May 15, 2020 · SEC filing
- Reported sold
- $100K Offering amount: $10.9M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- May 4, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2020 | Initial | $100,000 | No comparison | 3 | SEC filing |
| Oct 11, 2019 | Initial | $2,066,366 | No comparison | 31 | SEC filing |
| Aug 22, 2018 | Initial | $1,428,760 | No comparison | 7 | SEC filing |
| Jun 4, 2018 | Amendment | $4,930,000 | $540,000vs Apr 2, 2018 | 64 | SEC filing |
| Apr 2, 2018 | Amendment | $4,390,000 | No comparison | 48 | SEC filing |
| Sep 28, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 13, 2017 | Initial | $2,412,489 | No comparison | 16 | SEC filing |
| Oct 3, 2016 | Amendment | $2,500,000 | $1,977,000vs Jul 26, 2016 | 36 | SEC filing |
| Jul 26, 2016 | Initial | $523,000 | No comparison | 8 | SEC filing |
| Jan 12, 2016 | Initial | $1,138,600 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0
- Form D file number
- 021-367050
Convertible Promissory Note
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| North Capital Private Securities Corporation | 154559 | |
| Boustead Securities, LLC | 141391 |
Source: Form D, filed May 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Blake Anson | Executive |
| Marcus Boehm | Director |
| David Buche | Executive |
| Ryan Gordon | Executive |
| Kevin Gunderson | Director |
| Paul Hansen | Director |
| Dimas Jimenez | Executive |
| Murdoc Khaleghi | Executive |
| Andrew La Frence | Executive, Promoter |
| Sriram Nadathur | Director |
| Patrick O'shaughnessy | Director |
| Matthew Peris | Executive |
| Robert Petcavich | Director, Executive, Promoter |
| Steven Snyder | Director |
| Yung Ping Yeh | Director, Executive, Promoter |
| Fabian Zanella | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
13300 67th Ave N
Maple Grove, MN, 55311
Maple Grove, MN, 55311